In Global Health Research, Is It Legitimate To Stop Clinical Trials Early on Account of Their Opportunity Costs?

After the failure of three large clinical trials of vaginal microbicides, a Nature editorial stated that the microbicide field “requires a mechanism to help it make rational choices about the best candidates to move through trials” [1]. In this month's debate, James Lavery and colleagues propos...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavery, James V., Singer, Peter A., Ridzon, Renee, Singh, Jerome A., Slutsky, Arthur S., Anisko, Joseph J., Buchanan, David
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
The PLoS Medicine Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686164/
https://www.ncbi.nlm.nih.gov/pubmed/19513106
http://dx.doi.org/10.1371/journal.pmed.1000071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686164/
https://www.ncbi.nlm.nih.gov/pubmed/19513106
http://dx.doi.org/10.1371/journal.pmed.1000071

Ejemplares similares